Members

Covestro is a world-leading supplier of high-tech polymer materials: innovative, sustainable, and diverse.

We are serving key industries (such as automotive, construction, and electro/electronics) around the globe with technologically leading processes. Our products and application solutions are used in many areas of modern life.

In line with our vision “To make the world a brighter place,” we work on solutions to the challenges of our time. Alternative raw materials (such as biomass) and alternative production concepts (e.g. via biotechnology) are the basis for various new innovation-driven products and production processes.

With approximately 15,800 employees Covestro posted sales of 12.1 billion euros in 2015. It has some 30 major production sites worldwide that operate in a safe, efficient and ecofriendly way. The product range includes the high-performance polymer polycarbonate and precursors for polyurethanes that are used to produce foam.

Henkel operates globally with a well-balanced and diversified portfolio. The company holds leading positions with its three business units - Laundry & Home Care, Beauty Care and Adhesives - in both industrial and consumer businesses thanks to strong brands, innovations and technologies. Founded in 1876, Henkel looks back on more than 140 years of success. Henkel’s preferred shares are listed in the German stock index DAX. The DAX-30 company has its headquarters in Düsseldorf, Germany.

Henkel employs more than 50,000 people worldwide, over 80 percent of whom work outside of Germany. As a recognized leader in sustainability, Henkel holds top positions in many international ratings and rankings. In the fiscal year 2016, the company reported sales of approx. 18.7 billion euros and an operating profit of around 3.2 billion euros (adjusted for one-time gains/charges and restructuring charges).

Autodisplay brings proteins and peptides to the surface of gram negative bacteria. The transport of molecules to the bacterial surface avoids protein expression issues such as inclusion bodies and incorrect folding. With our proprietary cell surface display technology, we create custom-tailored solutions for our clients. Services include:

1. High-throughput screening of binding interactions and enhanced enzyme activity via FACS.

2. Development of whole cell biocatalysts that combine the benefits of soluble enzymes and classic whole cell biocatalysts - no limitations regarding permeability of substrate or product, yet easy recovery of the biocatalyst for re-use.

3. Functionalisation of solid surfaces with the highest levels of control regarding target molecule orientation. Autodisplay helps prevent the activity loss by-effect which occurs during immobilisation.

Bio Base Europe Pilot Plant is an open innovation pilot and demonstration facility for process development, scale-up and custom manufacturing of biobased products and processes from lab to multi ton scale. A wide and flexible spectrum of modular unit operations combined with a team of highly trained and experienced engineers, process operators and technicians facilitates the translation of biobased laboratory processes into viable industrial processes.

Bio Base Europe Pilot Plant has successfully performed 200 projects for more than 100 companies and has been involved in over 30 public projects. It currently coordinates SmartPilots (Improve policies in support of shared pilot facilities and their users) and BioBase4SME (Bio-innovation support for entrepreneurs throughout North-West Europe).

The Bioprocess Pilot Facility B.V. is a unique open access facility, situated at the Biotech Campus Delft, the Netherlands. Companies and knowledge institutions can upscale new sustainable production processes by converting bio-based residues into useful chemicals or fuels and production processes for Food and Pharma.
The facility has been specifically designed to enable the transition from laboratory to industrial scale.

We have 4 different pilot plants which can interact:
· Pretreatment of biomass on benchscale and pilot scale.
· Fermentation from 10 l up to 8m3. (ATEX, GMO)
· Downstream processing, chemical processing (ATEX)
· Food grade pilot plant.

The upscaling of the lab process can be proven on pilot scale with a good prediction of the process on commercial scale.

DASGIP has been an industry-leading supplier of benchtop bioreactor solutions for the biotech, pharmaceutical and chemical industries as well as academia and research institutions, since 1991. Our Parallel Bioreactor Systems for the cultivation of microbial, plant, animal and human cells utilize industry-standard benchtop glass and single-use bioreactors.

DASGIP's best-in-class configurable control systems and state-of-the-art bioprocess analyzers deliver unparalleled functionality coupled with user-friendly design for optimal bioprocessing. Our proven solutions for interconnectivity to 3rd party bioprocess analyzers, supervisory control systems and DoE tools, combined with our best-in-class control systems, enable migration strategies for optimization of legacy benchtop bioreactor equipment. The outstanding DASGIP bioprocess solutions support QbD-driven process development.

With effect from January 2012 DASGIP is an Eppendorf company. DASGIP is headquartered in Juelich (Germany) and has operations throughout Europe, North America and Asia.

Direvo is a biotechnology company with a focus on the biomass conversion industry. Direvo applies its profound expertise in bioengineering to provide custom solutions for partners in areas that include: Protein & Enzyme Engineering, Application Development and Process Engineering.

Evolva stands for a world where there is less sugar in your food, you and your family are safe from biting ticks, and your cat lives longer - and that’s just for starters. We aim to make such things possible by discovering, producing, and supplying innovative, sustainable ingredients. Evolva is a pioneer and global leader in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition. Our products include stevia, resveratrol, vanillin, nootkatone, valencene and saffron. As well as developing our own proprietary ingredients, Evolva also deploys its technology for partners, providing them with a competitive edge and sharing in the returns they make.

To learn more about us please watch our YouTube movie “Eve explains Evolva’s fermentation” and follow @EvolvaTweets on Twitter

evoxx technologies GmbH, a German Industrial Biotechnology Company, is focusing on the development and production of industrial enzymes and novel carbohydrate ingredients produced by enzymatic bioconversion. With its proprietary enzymes and carbohydrate ingredients, evoxx is active in high growth markets addressing consumer needs in the Global Food Health & Wellness Sector and Consumer Products Markets.

The company Heinrich Frings GmbH & Co. KG is a worldwide supplier of machines, equipment and components for process technology in the industry sectors food, biotechnology and chemical industry as well as environmental technology with special focus on fermenters/ bioreactors.

FRINGS not only supplies customized systems for each application, but it also offers assistance and consulting services with its know how and experience concerning process optimization and product development. For downstream processing FRINGS delivers membrane filtration systems (crossflow filtration) for many different industry sectors.

IMD Natural Solutions is a Natural Product chemistry expert, active in the area of fine chemicals derived from natural sources. We develop and produce innovative natural additives for product preservation in open and closed shelf-life and hygiene applications and deliver services related to Natural Products:

• Discovery and qualification of lead candidates and active (pharmaceutical) ingredients
• Process development and production (fermentation / extraction-based)

• World largest pure Natural Product compound collection (15000 compounds)
• Screening library (100,000 samples, HTS-ready plated)
• Bioprofiling database (unparalleled collection of bioactivity data; 12 million entries)
• Fermentation, purification, analytical lab (uPLC-MS/UV/ELSD; GC/MS; NMR)

The Jäckering group of companies has developed over 100 years (date of foundation 1910) into a small group of various activities:

- wheat starch production (ca. 300.000 tons wheat input per year)

- machinery production (grinders and dryers on the bases of air turbulence mills)

- by-product-recycling in the PVC industry

- logistics and warehousing

Jäckering disposes of a relatively large industrial site in the harbour of Hamm (harbour Hamm is one of the largest canal harbours in Germany), with neighbouring companies in the businesses of vegetable oil production, animal feed compounding as weil as a petrochemical harbour for mineral oil, heating oil, etc„ Jäckering plans to move into biotechnology production of raw materials for the chemical industry on the bases of its by-products, this could be Butandiol, Butanol or Butadien.

Same research is already carried out together with leading university institutes, and a technical application center is under construction.

Founded in 2005, LanzaTech has developed a fully integrated gas to liquid technology platform that produces fuels and chemicals from gas resources. The potential feedstock ranges from industrial waste gases (steel mills, refi neries and phosphorous plants) to biomass syngas (MSW, organic industrial waste, and agricultural waste); as well as biogas.

LanzaTech employs a strong technical team based in the USA, China and Europe and has a rapidly growing patent portfolio. With agreements now in place across a variety of sectors internationally, including steel, aviation, refi ning and chemicals, LanzaTech’s technology is being scaled to commercial production.

Mitsui & Co. Deutschland GmbH is a subsidiary of Mitsui & Co., Ltd., one of the largest general trading companies in Japan with an annual revenue of 39,672 million USD (2016/17). Utilizing our global operating locations, network and information resources, we are multilaterally pursuing business that ranges from product sales, worldwide logistics and financing, through to the development of major international infrastructure and other projects in the following fields: Iron & Steel Products, Mineral & Metal Resources, Infrastructure Projects, Integrated Transportation Systems, Chemicals, Nutrition & Agriculture, Energy, Food, Food & Retail Management, Healthcare & Service, Consumer Business, IT & Communication Business, Corporate Development Business.

We favour renewable over finite-supply, but prefer those technologies that require little or no subsidies to thrive, commercially viable concepts will ultimately stand the test of time. We believe the best long-term effects are achieved when each component in biomass is utilised to its full potential.

Applied research for your needs

As a private and independent institute, nova has over two decades of experience in the bio- and CO2-based economy, conducting research projects and consultancy as well as conference management and dissemination.

nova experts come from a wide range of backgrounds, including material sciences, economics, chemistry, biology, environmental sciences, biotechnology and physics. This gives nova a unique understanding of the bio-based economy, markets and trends and enables it to support your business. nova surrounds, strengthens and completes scientific and engineering work by linking it to feedstock, markets, ecology, economy and policy. nova offers research and consultancy with a focus on bio-based economy in the fields of feedstock, techno-economic evaluation, markets, sustainability, dissemination, B2B communication and policy.

Pfeifer & Langen operates five sugar factories in Germany. Sugar beets grown by farmers are processed to white sugar and the by-products sugar beet pulp and molasses. These products and intermediate products such as thick juice can be used as carbohydrate sources for biotechnological processes.

Pfeifer & Langen supplies sugar and sugar specialities for the food industry and the consumers. The production process of Pfeifer & Langen starts when the sugar beet seed is sold to the farmers and ends when the sugar is placed on the shelves of groceries. We are looking for opportunities to use our expertise in the process chain beginning with agriculture and ending in the food retail trade for new processes and products connected with biotechnology.

Newly Pfeifer & Langen enters the field of natural functional carbohydrates.

Phytowelt GreenTechnologies GmbH is a young, innovative company offering contract research and production in plant and industrial biotechnology worldwide. Our tissue culture and genetic engineering know-how assists our clients for the optimization of plants as well as utilization of secondary metabolites and enzymes for industrial use.

Phytowelt routinely applies key technologies such as in vitro cultivation of plants, cell fusion, transformation technologies as well as plant analysis and molecular marker assisted breeding. Our approach to link plant and industrial biotechnology is maximizing the synergy from our platform technologies phytodiversity and phytomining to support the aroma and pharmaceutical industry and other users of secondary metabolites and enzymes of plants. Phytowelt GreenTechnologies was created in January 2006 as a merger of Phytowelt GmbH and GreenTec GmbH (created in 1997), a spin-off company from the Max-Planck-Institute for Plant Breeding Research, Cologne.

As an ‘all-in-one’ protein engineering service provider, SeSaM-Biotech improves industrial enzymes for various industry sectors like the chemical, dish&fabric, feed and food sector. Our expertise covers a range of enzymes including amylases, lipases, esterases, cellulases, glucose oxidases, laccases, monooxygenases, phytases, proteases, pectinases, polymerases and isomerases which we already have improved towards e.g. higher activity, thermal resistance or many other characteristics. With our cutting-edge technologies for mutagenesis (e.g. SeSaM-Technology, OmniChange), computational modelling of enzymes, and individually adapted screening assays we follow our vision:

To provide our clients with ‘Quality Enzyme Solutions’ to make their products eco-friendler, more cost effective and more valuable.

Smart Bioprocess consults companies in bioprocess development and innovation management in industrial and pharmaceutical biotechnology.

With more than 15 years practice in bioprocess development we consult you in all stages of the development process: screening, media optimization, fermentation optimization, technology selection and scale up. Our special focus is the implementation and application of microbioreactors and automation to accelerate the development process.

Through our experience in establishing new technology in international markets we guide start-ups and SMEs through the innovation process from idea to product. In the innovation process we apply Design Thinking and Agile Project Management for the efficient progress of your product and ideas.

Our German and international business network will help to enter new markets and establish your business.

With Smart Tools to Smart Bioprocess.

Syngip is a next generation carbon capture biotechnology company. Syngip engineers carboxydotrophic bacteria to produce biochemicals and biofuels from syngas and carbon waste gases (gases containing CO and/or CO2, H2). Currently, the main focus lies on the development of microbial biocatalysts for the production of light olefins.

CeBiTec is one of the largest faculty-spanning central academic institutions at Bielefeld University. Its purpose is to bundle the biotechnological activities and research projects at the university, to foster cross-linking of research approaches and technologies from different research fields and to develop innovative projects within its two main research areas ‘Large Scale Genomics and Big Data Bioinformatics’ and ‘Metabolic Engineering of Unicellular Systems and Bioproduction’.

Russian Academy of Sciences was organized through merging the A.N. Bach Institute of Biochemistry RAS (INBI RAS), the S.N. Winogradsky Institute of Microbiology RAS and the Centre «Bioengineering» RAS.

The Research Centre of Biotechnology RAS carries out basic and applied research in the fields of biochemistry and biotechnology, microbiology, genomics, bioengineering and genetic engineering, biocatalysis, system and structural biology, biogeotechnologies, bioremediation, agrobiotechnologies, food quality and safety.

Fraunhofer UMSICHT is a pioneer for sustainable energy and raw materials management. The institute provides scientific results and transfers them to business, society, and politics. The dedicated team researches and develops sustainable products, processes and services.

We offer process engineering research and development services as well as products and processes incl. industrial property rights. These help to meet the increasing demands for affordable sustainability and innovation in chemistry, petro-chemistry and refinery. Our know-how encompasses the areas of fine and specialty chemicals (organic acids, peptides, sugars, surfactants), polymers (monomer syntheses, polymerization, polycondensation) as well as chemical mass products (alcohols, naphtha) and biofuels (diesel, kerosene). Biomass, synthesis gas and selected residues constitute the portfolio of raw materials from which we suggest process-specific solutions. Know-how regarding the upstream and downstream processing as well as product formulation round out our expertise.

Genetika carries out fundamental and applied research in the fields of Microbiology, Genetic Engineering and Biotechnology with the emphasis to development of processes based on microorganisms as well as mammalian cells.

Genetika is the home of Russian National Collection of Industrial Microorganisms (VKPM) – the biggest collection of this type in the country. It boasts ca. 17000 strains of different bacterial, yeast and fungal species. Principal research areas: microbial strains and cell cultures design; process development and optimization; regulation and evaluation of metabolic processes; biocatalytic processes development. Based on Genetika is the editorial board of the Russian Journal of Biotechnology.

Genetika is one of the key member of Russian Technology Platform “Bio-industry and Bio-resources – BioTech2030”, working in the area of implementation of a number of biotech projects, including the technologies of amino acids, organic acids, enzymes and other value-added products.

Giessen University is a modern institution which can take pride in some four centuries of past achievement. The current research activities in biotechnology build bridges from biological and biochemical phenomena to industrial applications. Key aspects comprise the development of novel tools for bio-analytics (e.g. mass spectrometry imaging), protein design (programmable nucleases, photoswitches), and the field of food biotechnology (basidiomycetous enzymes, natural flavors, fermentation.

The NJUT's Faculty of Biotechnology originated from the first discipline in biochemical engineering in China in 1985, which has been leading the way in the higher education and R＆D in biotechnology from then on. Prof. OUYANG Pingkai, the founder of the Faculty and Academician of the Academy of Engineering of China, pioneered biochemical engineering as a mentor and an investigator.

Philipps-Universität in Marburg is the oldest university in the world that was founded as a Protestant institution. It has been a place of research and teaching for nearly five centuries. It`s broad range of arts and humanities, and its experimentally challenging scientific work, constitute an ideal platform for interdisciplinary cooperation.

We are experts in biocatalyst engineering with a focus on directed protein evolution. We are developing novel random mutagenesis methods (SeSaM: Sequence Saturation Method), high throughput screening systems and computational programs to manage the complexity of protein sequence space. Based on our core competencies in directed protein evolution we founded a company (SeSaM-Biotech) and collaborate with leading companies in the field of industrial biotechnology.

Scion is a New Zealand Crown Research Institute that specialises in research, science and technology development for the forestry and wood-derived materials: tree improvement, wood-related bioenergy, industrial biotechnology and high-value manufacturing.

Scion is developing biorefinery processes to create new green chemicals and biopolymers from renewable resources, with a focus on lignocellulosic biomass: soft wood.

We develop microbial and enzyme-based processes that can be used by industrial partners for the production of valued compounds, enzymes and other biological products.

Scion is New Zealand's centre of expertise in bioplastic research and development: production and manufacturing of biopolymers as plastics, adhesives, coatings, foams, pulp/packaging, and fibre-composites.

To explore the potential of nature to improve the quality of life

Wageningen University and Research is a joint venture between the Wageningen University, which focuses on education and fundamental research, and Wageningen Research which conducts applied research directly for industry. In CLIB2021, the WUR is represented by five academic chair group - Bioprocess Engineering, Microbiology, Systems and Synthetic Biology, Environmental Technology and Biobased Commodity Chemistry – and by the applied research centre Food & Biobased Research (WFBR).

NRW.BANK is the development bank for North Rhine-Westphalia. It essentially orients itsNRW.BANK is the development bank for North Rhine-Westphalia. NRW.BANK essentially gears its equity capital products to companies’ lifecycles. Using the new programme “NRW. SeedCap Digitale Wirtschaft”, business angels’ small-volume early-stage investments in companies of the digital economy can be doubled by the NRW.BANK. The regional seed funds of the NRW.BANK.Seed.Fonds-Initiative and the NRW.BANK.Venture Fonds invigorate the early-phase funding in NRW.

With over €660m in assets under management as of the end of 2016, Seventure Partners is a leading venture capital fi rm in Europe. Since 1997, Seventure Partners has invested in innovative businesses with high growth potential in two fi elds: Digital technologies in France and Germany, and Life sciences across Europe, Israel, Asia and North America.

In Life sciences, the four areas of focus include biotechnology and pharmaceuticals, connected/digital health and medtech, industrial biotechnology, and last but not least: the MICROBIOME, nutrition, foodtech and personalized medicine.

Investments can range between €500k and €10m per round, or up to €20m per company, from early to late stage. Recently, Seventure Partners successfully launched Health for Life Capital™ which has attracted strategic investments from prestigious organizations including Danone, Tereos, Tornier, Lesaff re, Bel and Novartis, as well as entrepreneurs and fi nancial institutions.

Sofinnova Partners is a leading European venture capital firm specialized in Life Sciences. Based in Paris, France, the firm brings together 12 highly experienced investment professionals from all over Europe, the US and China. The firm focuses on paradigm shifting technologies alongside visionary entrepreneurs.

Sofinnova Partners seeks to invest as a founding and lead investor in start-ups and corporate spin-offs, and for more than 40 years has backed nearly 500 companies creating market leaders around the globe. Today, Sofinnova Partners has over 1.3 billion of funds under Management.

Arnold & Porter Kaye Scholer is an international law firm with over 1,000 lawyers in 13 offices around the world. The Frankfurt Biotech/Pharma team has substantial experience relating to partnership alliances, licensing, technology transactions, distribution agreements, strategic partnerships and investments, protection of intellectual property, financing matters, corporate and tax optimized structuring. In our London office, a team of highly reputed attorneys is dedicated to regulatory issues in the chemicals, healthcare and other industries. The firm’s clients range from individuals and small/medium sized companies to large international corporations.

CNP Consultants GmbH is an acknowledged consulting company specialized in the branches biotech, chemistry, nanotech and pharma (BCNP).

BCNP's clients benefit from the very broad basis of natural scientific expertise of its consultants in the disciplines inorganic chemistry, biochemistry, biology, biotechnology, molecular biology, polymer chemistry and business chemistry. The team is completed by an experienced finance expert and a specialist for international marketing and branding.

Your reliable partner for scouting, bioprojects and consultation.

Featuring:

“Window to China” - provides you with competent and up-to-date information on Chinese bio R&D, based on press releases, reports and professional network information in Chinese language. Overcome the language barrier and stay informed about the growing biocommunity of China!

Other features:

„Window to Japan“ - newsletter, website and database

„Profiler“ - whom are you talking to in China and Japan?

„Customer search“ - an evidence-based approach to Marketing

BIO-ARCC Drayton Valley Ltd. is the not-for-profit company that will administer the Bio-Mile bio-industrial park located in Drayton Valley, Alberta, Canada. The region has abundant forestry and agricultural resources and the goal is to manufacture a vast array of industrial and consumer products which are presently based on fossil fuels. Currently, there is a fibre mat plant under construction for the manufacture of biocomposites. In addition, there is a co-gen plant using forestry waste for the production of electricity. The goal is to expand into the production of green chemicals.

BioRiver - Joining forces for Life Sciences & Biotechnology

Founded in 2004, BioRiver – Life Science im Rheinland e.V. is fully committed to representing the Life Sciences sector in the bioregion Rhineland as an independent industry organization. The essential aims of BioRiver are to build a strong network within the biotech sector, to improve the political and economic conditions as well as to market the bioregion Rhineland and its members. Thanks to the strong profiles of the partners in the network, it has been possible to initiate various collaboration projects and gain direct access to experts in both business and academia.

KADIB offers expertise in Global Industrial Bioeconomy. We strive to position profitable chemical and energy value chains sustainably in the Political, Economical, Societal, Technological, Legislative and Ecological(PESTLE) environment and conditions.

KADIB works through its unique network of senior experts. We help our clients to specify complex queries and provide analyses and reports through our Advisory Board and wider network.

Bioeconomy Corporation is the lead development agency for the bio-based industry in Malaysia, under the purview of Ministry of Science, Technology, and Innovation (MOSTI). Bioeconomy Corporation is:

- Owned by the Minister of Finance Incorporated & Federal Lands Commissioner

- Governed by the Biotechnology Implementation Council

- Advised by the Bioeconomy International Advisory Panel, chaired by the Honorable Prime Minister of Malaysia.

Bioeconomy Corporation is responsible for executing the objectives of the National Biotechnology Policy (NBP) and acts to identify value propositions in both R&D and commerce and to support these ventures via financial assistance and developmental Services.

PROvendis acts as a professional service provider in the entire field of IP management for more than 30 universities and extra-university research institutions as well as for companies and start-ups.

We provide an exclusive access to licensable inventions of approx. 20,000 scientists from the areas of medicine, natural sciences and engineering. Our Life Sciences Team consists of experienced innovation managers with professional expertise in the fields of biology, chemistry, medicine and pharma. They identify suitable partners, negotiate license agreements and promote long-term research collaborations.